CEO Spacecode Healthcare
Olivier served as CEO of Biosafe Group Geneva Area, Switzerland from April 2012 to July 2016, a company active in lab automation for stem cells, regenerative medicine & immunotherapy. Olivier worked with Biosafe for a total of 15 years, helping grow the company from four to 100 employees, expand into five locations and led a successful acquisition of the company by GE Healthcare in 2016.
Following the acquisition, Olivier worked at GE Healthcare, as General Manager Cell Banking and Point of Care. He oversaw the integration of Biosafe into GE Cell Therapy business unit as well as focusing on Cord Blood Banking, Transplantation & Personalized medicine, with a key milestone, securing the first and major deal of Biosafe’s product in China ($12 Million) by partnering with a private cord blood bank.
Olivier studied engineering at ETS Geneva and was raised in Sao Paulo.